American Society of Clinical Oncology Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer
- 15 July 2004
- journal article
- guideline
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (14) , 2927-2941
- https://doi.org/10.1200/jco.2004.04.579
Abstract
Purpose To develop a clinical practice guideline for the management of men with metastatic, recurrent, or progressive carcinoma of the prostate. The focus of this document is on the use, combinations, and timing of various forms of androgen deprivation therapy (ADT) for the palliation of men with androgen-sensitive disease. Methods An expert panel and writing committee were formed. The questions to be addressed by the guideline were determined, and a systematic review of the literature was performed, which included a search of online databases, bibliographic review, and consultation with content experts. A priori criteria were used to select studies for analysis and study authors were contacted when necessary. Results There were 10 randomized controlled trials, six systematic reviews, and one Markov model available to inform the guidelines. Conclusion A full discussion between practitioner and patient should occur to determine which therapy is best for the patient. Bilateral orchiectomy or luteinizing hor...Keywords
This publication has 49 references indexed in Scilit:
- The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapyThe Lancet Oncology, 2003
- International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2002
- Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinomaCancer, 2002
- A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate CancerJournal of Urology, 2002
- Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?Prostate Cancer and Prostatic Diseases, 2001
- Recovery of Serum Testosterone, LH and FSH Levels Following Neoadjuvant Hormone Cytoreduction and Radical Radiotherapy in Localized Prostate Cancer*Clinical Oncology, 2001
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Severe Hepatocellular Dysfunction following Cyproterone Acetate TherapyBritish Journal of Urology, 1991
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Reconsideration of Orchiectomy in the Treatment of Advanced Prostatic CarcinomaSouthern Medical Journal, 1977